A next generation GLP-3 triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously
Increasing clinical research and emerging approvals for GLP-1 therapies in younger populations are enabling safer and more effective treatment options for adolescents
Genes selected for TaqMan RT-PCR and the corresponding hydrolysis probe references (Life Technologies, CA, USA) are listed in Supplementary Table 1
doi: 10.1530/joe-18-0374 28 YamamotoCMiyoshiHOnoKSugawaraHKamedaRIchiyamaMet al
Long-term use may also reduce vitamin B12 absorption, warranting periodic monitoring during extended therapy (Top et al., 2022)
Meanwhile, even though Zepbound and Mounjaro have the same dosing regimen, their recommended maintenance doses differ, too